In contrast, HRD-low patients exhibit an increasing trend in maxVAF, suggesting resistance to post-surgical adjuvant treatment and a higher risk of recurrence.
← all excerpts
Genomic and transcriptomic data reveal molecular differences between homologous recombination deficiency subgroups in Chinese ovarian cancer patients.
1
—
—